Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,963.5 | 146.95 | 4,67,870.32 | 1,115.14 | 0.82 | 5,641.31 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 8,585 | 73.75 | 2,20,945.52 | 891 | 0.36 | 2,974 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 5,050 | 93.08 | 1,90,906.63 | 492 | 0.67 | 4,073 | 222.76 |
Cipla Ltd CIPLA | 1,474.4 | 36.19 | 1,18,672.48 | 862.16 | 0.88 | 4,672.12 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,121 | 30.17 | 1,11,346.37 | 1,722 | 0.09 | 3,564.6 | 237.3 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
